We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Jul 2019 to Jul 2024
"MOL: New Assets' Peak 16M-18M Boepd Production in 2018, 2019 at 0750 GMT and "MOL Buys Offshore UK Upstream Assets from Wintershall for $375M," at 0830 GMT misstated the output in barrels a day in the headline and in the fifth paragraph. Oil production from the Broom area will contribute roughly 1,000 barrels of oil equivalent a day to MOL in 2014 while the acquired portfolio could contribute 6,000 barrels a day in 2015. The combined peak production of the assets is expected to reach 16,000 to 18,000 barrels a day in 2018 and have peak production through 2019, MOL added.
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
